Azetukalner

Drug identity checked against registry records

Also recorded as XEN1101

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderNCT06775379XENEPhase 3Terminated2026-10-28Actual
An Open-label Study of Azetukalner in Bipolar I or II Depression (X-CEED-OLE)NCT07217860XENEPhase 3Active not recruiting2029-06Estimated
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)NCT07076407XENEPhase 3Active not recruiting2027-05Estimated
An Open-Label Study of Azetukalner in Major Depressive DisorderNCT06922110XENEPhase 3Active not recruiting2027-01Estimated
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)NCT07172516XENEPhase 3Active not recruiting2028-06Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.